peptídeo dsip Research Compound Unraveling the Mysteries of DSIP

No representations or warranties are made regarding safety or efficacy for any purpose outside of controlled research settings.

thigh) has a minimal impact on the GHK-Cu half life

GHK (glycyl-L-histidyl-L-lysine) is a human plasma copper-binding peptide that declines during aging

The one human trial that will measure tolerability directly has not started reporting it is only recruiting (planned 2026), studies a topical gel on small standardized wounds , and lists safety as a secondary, not primary, outcome (NCT07437586)

the estimated oral dose range from animal research is approximately 18 mg/kg, which translates to high absolute doses in humans

the guide cannula measured 2.5 cm in overall length and was prepared with a heat bulge placed 2.5 mm from its beveled tip, thus acting as a stop to control the depth of penetration